甘李药业：任命贾婷为副总裁兼首席医学官，加速创新药全球化布局

Core Insights - Gan Li Pharmaceutical announced the appointment of Jia Ting as Corporate Vice President and Chief Medical Officer, responsible for the company's operations in Europe and the United States [1] - The Chairman and CEO of Gan Li Pharmaceutical, Chen Wei, expressed confidence that Jia Ting's involvement will accelerate the global registration and clinical development of new drugs [1] Company Overview - Jia Ting holds a medical doctorate from Karolinska Institute in Sweden and has over 15 years of experience in research and global clinical development in metabolic diseases, focusing on diabetes, obesity, kidney diseases, and other chronic metabolic conditions [1] - Prior to joining Gan Li Pharmaceutical, Jia Ting worked at Novo Nordisk, overseeing the lifecycle management of multiple innovative drugs and successfully facilitating product approvals and indication expansions in major markets including the US, Europe, and China [1]